Literature DB >> 26230905

Adherence to Oral Maintenance Treatment in Adolescents With Inflammatory Bowel Disease.

Lieke M Spekhorst1, Thalia Z Hummel, Marc A Benninga, Patrick F van Rheenen, Angelika Kindermann.   

Abstract

OBJECTIVES: The aim of this study was to systematically review the rates of nonadherence to oral maintenance treatment in adolescents with inflammatory bowel disease (IBD), and to describe perceived barriers to adherence and psychosocial factors involved.
METHODS: The article considered studies published in MEDLINE, Embase, and PsycINFO up to March 2015. Studies that had collected data on adherence to thiopurines or aminosalicylates in a cohort of adolescents with IBD. Case reports and case series were excluded.
RESULTS: A total of 25 studies were included. Lack of uniformity of outcome measures made pooling of data impossible. Rates of medication nonadherence ranged from 2% to 93%. The most frequently reported barriers were "just forgot," "wasn't home," and "interferes with activity." Family dysfunction, peer victimization, poor health-related quality of life, poor child-coping strategies, anxiety, and depressive symptoms were associated with medication nonadherence.
CONCLUSIONS: Nonadherence to oral maintenance therapy in adolescents with IBD is a significant health care problem and can lead to unnecessary escalation in therapy. Difficulties in family and social interactions, and psychosocial dysfunction can jeopardize IBD treatment outcome and should receive attention early in the course of the disease.

Entities:  

Mesh:

Year:  2016        PMID: 26230905     DOI: 10.1097/MPG.0000000000000924

Source DB:  PubMed          Journal:  J Pediatr Gastroenterol Nutr        ISSN: 0277-2116            Impact factor:   2.839


  14 in total

1.  Depression and medication nonadherence in childhood-onset systemic lupus erythematosus.

Authors:  A M Davis; T B Graham; Y Zhu; M L McPheeters
Journal:  Lupus       Date:  2018-06-28       Impact factor: 2.911

2.  College inflammatory bowel disease (C-IBD) day: a targeted approach to shared decision-making in college age students with IBD-a 2-year pilot project.

Authors:  Kofi Clarke; Mohammad Bilal; Heitham Abdul-Baki; Paul Lebovitz; Sandra El-Hachem
Journal:  Int J Colorectal Dis       Date:  2017-02-13       Impact factor: 2.571

3.  Greater number of perceived barriers to hydroxyurea associated with poorer health-related quality of life in youth with sickle cell disease.

Authors:  Arlene Smaldone; Deepa Manwani; Nancy S Green
Journal:  Pediatr Blood Cancer       Date:  2019-04-02       Impact factor: 3.167

Review 4.  Inflammatory Bowel Disease in Childhood and Adolescence.

Authors:  Jan Däbritz; Patrick Gerner; Axel Enninger; Martin Claßen; Michael Radke
Journal:  Dtsch Arztebl Int       Date:  2017-05-12       Impact factor: 5.594

5.  Perceived medication adherence barriers mediating effects between gastrointestinal symptoms and health-related quality of life in pediatric inflammatory bowel disease.

Authors:  James W Varni; Robert J Shulman; Mariella M Self; Shehzad A Saeed; George M Zacur; Ashish S Patel; Samuel Nurko; Deborah A Neigut; James P Franciosi; Miguel Saps; Jolanda M Denham; Chelsea Vaughan Dark; Cristiane B Bendo; John F Pohl
Journal:  Qual Life Res       Date:  2017-09-08       Impact factor: 4.147

6.  Psychological wellbeing and physical activity in children and adolescents with inflammatory bowel disease compared to healthy controls.

Authors:  Laura Mählmann; Markus Gerber; Raoul I Furlano; Corinne Legeret; Nadeem Kalak; Edith Holsboer-Trachsler; Serge Brand
Journal:  BMC Gastroenterol       Date:  2017-12-12       Impact factor: 3.067

Review 7.  Medication adherence in inflammatory bowel disease.

Authors:  Webber Chan; Andy Chen; Darren Tiao; Christian Selinger; Rupert Leong
Journal:  Intest Res       Date:  2017-10-23

Review 8.  Stress Triggers Flare of Inflammatory Bowel Disease in Children and Adults.

Authors:  Yue Sun; Lu Li; Runxiang Xie; Bangmao Wang; Kui Jiang; Hailong Cao
Journal:  Front Pediatr       Date:  2019-10-24       Impact factor: 3.418

Review 9.  Barriers to treatment: describing them from a different perspective.

Authors:  Francesca Devine; Taylor Edwards; Steven R Feldman
Journal:  Patient Prefer Adherence       Date:  2018-01-17       Impact factor: 2.711

10.  Comment on "Prevalence of Anxiety and Depression in Patients with Inflammatory Bowel Disease".

Authors:  Wenwen Lai; Shaohang Cai
Journal:  Can J Gastroenterol Hepatol       Date:  2018-12-16
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.